Halozyme Therapeutic (HALO)
$17.26 0.00 (0.00%)
17:18 EDT HALO Stock Quote Delayed 20 Minutes
Previous Close $17.26
Market Cap 2.48B
PE Ratio 33.19
Volume (Avg. Vol.)
Day's Range 17.26 - 17.26
52-Week Range 12.71 - 22.06
Dividend & Yield N/A (N/A)
HALO Stock Predictions, Articles, and Halozyme Therapeutic News
- From InvestorPlace
- From the Web
Why Foot Locker, Inc. (FL), Campbell Soup Company (CPB) and Halozyme Therapeutics, Inc. (HALO) Are 3 of Today’s Worst Stocks
Foot Locker (FL), Campbell Soup (CPB) and Halozyme Therapeutics (HALO) shareholders won't be starting the weekend in the best of moods.
These small-cap stocks all have the potential to dish out misery, but if things work out just right, look out above.
3 Stocks to Watch on Thursday: Kohl’s Corporation (KSS), Halozyme Therapeutics, Inc. (HALO) and Sears Holdings Corp (SHLD)
Kohl's (KSS) is battered by an awful holiday performance, Sears (SHLD) sells off Craftsman and Halozyne (HALO) reports strong trial data.
Partnerships with the likes of ABV, PFE and LLY are helping Halozyme (HALO) stock turn toward the upside.
he current market cap for Halozyme Therapeutics (HALO) is at $1.5 billion, which makes it ripe as a takeover target.
Healthcare stocks rose broadly on Wall Street on Monday, with the sector seeing an overall increase of 0.3%.
Healthcare stocks advanced 0.8% on Wall Street on Friday morning.
Healthcare stocks declined broadly on Wall Street on Monday, with the sector seeing an overall decline of 1.7%.
Healthcare stocks finished down broadly on Wall Street on Monday, with the sector seeing an overall decline of 1.7%.
Healthcare stocks declined 1.9% on Wall Street today.
Healthcare stocks finished down broadly on Wall Street today, with the sector seeing an overall decline of 1.8%.
Healthcare stocks declined 2.0% on Wall Street on Monday.
Healthcare stocks finished down broadly on Wall Street today, with the sector seeing an overall decline of 0.6%.
Healthcare stocks declined 0.5% on Wall Street on Wednesday morning.
Healthcare stocks declined on Wall Street on Tuesday morning, down 0.6%.
Healthcare stocks fell on Wall Street on Friday morning, down 0.6%.
Healthcare stocks finished flat today on Wall Street.
Healthcare stocks finished flat on Monday on Wall Street.
Investors in Halozyme Therapeutics Inc (HALO) saw new options become available this week, for the May 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the HALO options chain for the new May 15th contracts and identified one put and one call contract of particular interest.
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys.
The directors of a company tend to have a unique inside view into the business, so when directors make major buys, investors are wise to take notice. Presumably the only reason a director of a company would choose to take their hard-earned cash and use it to buy stock in the open market, is that they expect to make money — maybe they find the stock very undervalued, or maybe they see exciting progress within the company, or maybe both..
Navellier RatingsPowered by Portfolio Grader